B cell homeostasis is disturbed by immunosuppressive therapies in patients with ANCA-associated vasculitides

Autoimmunity

Volumn 46, Issue 7, 2013, Pages 429-438

  Thiel, Jens ^a   Salzer, Ulrich ^a   Hässler, Fabian ^a   Effelsberg, Nora M ^a   Hentze, Carolin ^a   Sic, Heiko ^a   Bartsch, Marit ^a   Miehle, Nikolaus ^b   Peter, Hans Hartmut ^a   Warnatz, Klaus ^a   Schlesier, Michael ^a   Voll, Reinhard E ^a   Venhoff, Nils ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

^b Acura Klinik   (Germany)

Author keywords

Antineutrophil cytoplasmic antibody (ANCA); B lymphocytes; Cyclophosphamide; Granulomatosis with polyangiitis (GPA, Wegener's); Rituximab

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN A; GLUCOCORTICOID; IMMUNOGLOBULIN; IMMUNOSUPPRESSIVE AGENT; LEFLUNOMIDE; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; RITUXIMAB;

ADULT; ANCA ASSOCIATED VASCULITIS; ARTICLE; B LYMPHOCYTE; BLOOD ANALYSIS; CELL MATURATION; CONTROLLED STUDY; DISEASE ACTIVITY; FEMALE; HOMEOSTASIS; HUMAN; HUMAN CELL; IMMUNOSUPPRESSIVE TREATMENT; LOW DRUG DOSE; LYMPHOCYTOPENIA; MAJOR CLINICAL STUDY; MALE; MEMORY CELL; PRE B LYMPHOCYTE;

ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY-ASSOCIATED VASCULITIS; ANTIBODIES, MONOCLONAL, MURINE-DERIVED; AZATHIOPRINE; B-LYMPHOCYTE SUBSETS; CYCLOPHOSPHAMIDE; FEMALE; HOMEOSTASIS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; ISOXAZOLES; LYMPHOCYTE COUNT; MALE; METHOTREXATE; MIDDLE AGED; MYCOPHENOLIC ACID;

EID: 84885436190     PISSN: 08916934     EISSN: 1607842X     Source Type: Journal    
DOI: 10.3109/08916934.2013.798652     Document Type: Article

References (48)

1. Carsetti, R., M. M. Rosado, and H. Wardmann. 2004. Peripheral development of B cells in mouse and man. Immunol Rev. 197: 179-191. (Pubitemid 38142176)
2. Csernok, E., M. Ai, W. L. Gross, D. Wicklein, A. Petersen, B. Lindner, P. Lamprecht, et al. 2006. Wegener autoantigen induces maturation of dendritic cells and licenses them for Th1 priming via the protease-activated receptor-2 pathway. Blood. 107: 4440-4448. (Pubitemid 43801371)
3. Culton, D. A., M. W. Nicholas, D. O. Bunch, Q. L. Zhen, T. B. Kepler, M. A. Dooley, C. Mohan, et al. 2007. Similar CD19 dysregulation in two autoantibody-associated autoimmune diseases suggests a shared mechanism of B-cell tolerance loss. J Clin Immunol. 27: 53-68. (Pubitemid 46224934)
4. Haubitz, M., A. Dhaygude, and A. Woywodt. 2009. Mechanisms and markers of vascular damage in ANCA-associated vasculitis. Autoimmunity. 42: 605-614.
5. Radice, A., and R. A. Sinico. 2005. Antineutrophil cytoplasmic antibodies (ANCA). Autoimmunity. 38: 93-103. (Pubitemid 40515009)
6. Pillai, S., H. Mattoo, and A. Cariappa. 2011. B cells and autoimmunity. Curr Opin Immunol. 23: 721-731.
7. Holden, N. J., J. M. Williams, M. D. Morgan, A. Challa, J. Gordon, R. J. Pepper, A. D. Salama, et al. 2011. ANCA-stimulated neutrophils release BLyS and promote B cell survival: a clinically relevant cellular process. Ann Rheum Dis. 70: 2229-2233.
8. Adler, S., and P. M. Villiger. 2012. B cell strategy to maintain remission in ANCA-associated vasculitides? J Rheumatol. 39: 4-5.
9. Landolt-Marticorena, C., R. Wither, H. Reich, A. Herzenberg, J. Scholey, D. D. Gladman, M. B. Urowitz, et al. 2011. Increased expression of B cell activation factor supports the abnormal expansion of transitional B cells in systemic lupus erythematosus. J Rheumatol. 38: 642-651.
10. Stone, J. H., P. A. Merkel, R. Spiera, P. Seo, C. A. Langford, G. S. Hoffman, C. G. M. Kallenberg, et al.; RAVE-ITN Research Group. 2010. Rituximab versus cyclophosphamide for ANCA-associated vasculitis. N Engl J Med. 363: 221-232.
11. Hua, F., B. Wilde, S. Dolff, and O. Witzke. 2009. T-lymphocytes and disease mechanisms in Wegener's granulomatosis. Kidney Blood Press Res. 32: 389-398.
12. Wilde, B., M. Thewissen, J. Damoiseaux, P. van Paassen, O. Witzke, and J. W. C. Tervaert. 2010. T cells in ANCA-associated vasculitis: what can we learn from lesional versus circulating T cells? Arthritis Res Ther. 12: 204-213.
13. Voswinkel, J., G. Assmann, G. Held, S. Pitann, W. L. Gross, K. Holl-Ulrich, K. Herlyn, and A. Mueller. 2008. Single cell analysis of B lymphocytes from Wegener's granulomatosis: B cell receptors display affinity maturation within the granulomatous lesions. Clin Exp Immunol. 154: 339-345.
14. Thurner, L., A. Müller, M. Cérutti, T. Martin, J.-L. Pasquali, W. L. Gross, K.-D. Preuss, et al. 2011. Wegener's granuloma harbors B lymphocytes with specificities against a proinflammatory transmembrane protein and a tetraspanin. J Autoimmun. 36: 87-90.
15. Eriksson, P., C. Sandell, K. Backteman, and J. Ernerudh. 2010. B cell abnormalities in Wegener's granulomatosis and microscopic polyangiitis: role of CD25\+-expressing B cells. J Rheumatol. 37: 2086-2095.
16. Hoyer, B. F., I. M. Mumtaz, K. Loddenkemper, A. Bruns, C. Sengler, K.-G. Hermann, S. Maza, et al. 2012. Takayasu arteritis is characterised by disturbances of B cell homeostasis and responds to B cell depletion therapy with rituximab. Ann Rheum Dis. 71: 75-79.
17. Sims, G. P., R. Ettinger, Y. Shirota, C. H. Yarboro, G. G. Illei, and P. E. Lipsky. 2005. Identification and characterization of circulating human transitional B cells. Blood. 105: 4390-4398. (Pubitemid 40720786)
18. Roll, P., A. Palanichamy, C. Kneitz, T. Dorner, and H.-P. Tony. 2006. Regeneration of B cell subsets after transient B cell depletion using anti-CD20 antibodies in rheumatoid arthritis. Arthritis Rheum. 54: 2377-2386. (Pubitemid 44204997)
19. Venhoff, N., N. M. Effelsberg, U. Salzer, K. Warnatz, H.-H. Peter, D. Lebrecht, M. Schlesier, et al. 2012. impact of rituximab on Immunoglobulin concentrations and B cell numbers after cyclophosphamide treatment in patients with ANCA-associated vasculitides. PLoS One. 7: e37626.
20. Rakhmanov, M., S. Gutenberger, B. Keller, M. Schlesier, H.-H. Peter, and K. Warnatz. 2010. CD21low B cells in common variable immunodeficiency do not show defects in receptor editing, but resemble tissue-like memory B cells. Blood. 116: 3682-3683.
21. Visentini, M., V. Conti, C. Cristofoletti, C. Lazzeri, R. Marrapodi, G. Russo, M. Casato, and M. Fiorilli. 2012. Clonal expansion and functional exhaustion of monoclonal marginal zone B cells in mixed cryoglobulinemia: the yin and yang of HCV-driven lymphoproliferation and autoimmunity. Autoimmun Rev. 12: 430-435.
22. Wehr, C., T. Kivioja, C. Schmitt, B. Ferry, T. Witte, E. Eren, M. Vlkova, et al. 2008. The EUROclass trial: defining subgroups in common variable immunodeficiency. Blood. 111: 77-85.
23. Warnatz, K., and M. Schlesier. 2008. Flowcytometric phenotyping of common variable immunodeficiency. Cytometry B Clin Cytom. 74: 261-271.
24. Hellmich, B., O. Flossmann, W. L. Gross, P. Bacon, J. W. Cohen-Tervaert, L. Guillevin, D. Jayne, et al. 2007. EULAR recommendations for conducting clinical studies and/or clinical trials in systemic vasculitis: focus on anti-neutrophil cytoplasm antibodyassociated vasculitis. Ann Rheum Dis. 66: 605-617. (Pubitemid 46707128)
25. Thien, M., T. G. Phan, S. Gardam, M. Amesbury, A. Basten, F. Mackay, and R. Brink. 2004. Excess BAFF rescues self-reactive B cells from peripheral deletion and allows them to enter forbidden follicular and marginal zone niches. Immunity. 20: 785-798. (Pubitemid 38757447)
26. Rowland, S. L., K. F. Leahy, R. Halverson, R. M. Torres, and R. Pelanda. 2010. BAFF receptor signaling aids the differentiation of immature B cells into transitional B cells following tonic BCR signaling. J Immunol. 185: 4570-4581.
27. Wehr, C., H. Eibel, M. Masilamani, H. Illges, M. Schlesier, H.-H. Peter, and K. Warnatz. 2004. A new CD21low B cell population in the peripheral blood of patients with SLE. Clin Immunol. 113: 161-171. (Pubitemid 39296849)
28. Bohnhorst, J., M. B. Bjørgan, J. E. Thoen, J. B. Natvig, and K. M. Thompson. 2001. Bm1-Bm5 classification of peripheral blood B cells reveals circulating germinal center founder cells in healthy individuals and disturbance in the B cell subpopulations in patients with primary Sjögren's syndrome. J Immunol. 167: 3610-3618. (Pubitemid 32916053)
29. Anolik, J. H., J. Barnard, T. Owen, B. Zheng, S. Kemshetti, R. J. Looney, and I. Sanz. 2007. Delayed memory B cell recovery in peripheral blood and lymphoid tissue in systemic lupus erythematosus after B cell depletion therapy. Arthritis Rheum. 56: 3044-3056. (Pubitemid 47502752)
30. Reynaud, C.-A., M. Descatoire, I. Dogan, F. Huetz, S. Weller, and J.-C. Weill. 2012. IgM memory B cells: a mouse/human paradox. Cell Mol Life Sci. 69: 1625-1634.
31. Weill, J.-C., S. Weller, and C.-A. Reynaud. 2009. Human marginal zone B cells. Annu Rev Immunol. 27: 267-285.
32. Stegeman, C. A., J. W. Tervaert, W. J. Sluiter, W. L. Manson, P. E. de Jong, and C. G. Kallenberg. 1994. Association of chronic nasal carriage of Staphylococcus aureus and higher relapse rates in Wegener granulomatosis. Ann Intern Med. 120: 12-17. (Pubitemid 24011495)
33. Popa, E. R., C. A. Stegeman, C. G. M. Kallenberg, and J. W. C. Tervaert. 2002. Staphylococcus aureus and Wegener's granulomatosis. Arthritis Res. 4: 77-79.
34. Lidar, M., N. Lipschitz, P. Langevitz, and Y. Shoenfeld. 2009. The infectious etiology of vasculitis. Autoimmunity. 42: 432-438.
35. Salinas-Carmona, M. C., L. I. Perez, K. Galan, and A. V. Vazquez. 2009. Immunosuppressive drugs have different effect on B lymphocyte subsets and IgM antibody production in immunized BALB/c mice. Autoimmunity. 42: 537-544.
36. Zandvoort, A., M. E. Lodewijk, P. A. Klok, P. M. Dammers, F. G. Kroese, and W. Timens. 2001. Slow recovery of follicular B cells and marginal zone B cells after chemotherapy: implications for humoral immunity. Clin Exp Immunol. 124: 172-179. (Pubitemid 32587600)
37. Carsetti, R., M. M. Rosado, S. Donnanno, V. Guazzi, A. Soresina, A. Meini, A. Plebani, et al. 2005. The loss of IgM memory B cells correlates with clinical disease in common variable immunodeficiency. J Allergy Clin Immunol. 115: 412-417. (Pubitemid 40215112)
38. Rentsch, J., and G. McColl. 2000. Splenic infarction in Wegener's granulomatosis. J Rheumatol. 27: 1554-1555. (Pubitemid 30354064)
39. Gal, A. A., and J. J. Masor. 1996. Splenic involvement inWegener's granulomatosis. Arch Pathol Lab Med. 120: 974-977.
40. Di Sabatino, A., M. M. Rosado, R. Ciccocioppo, P. Cazzola, R. Morera, G. R. Corazza, and R. Carsetti. 2005. Depletion of immunoglobulin M memory B cells is associated with splenic hypofunction in inflammatory bowel disease. Am J Gastroenterol. 100: 1788-1795. (Pubitemid 41648435)
41. Di Sabatino, A., M. M. Rosado, L. Miele, F. Capolunghi, P. Cazzola, P. Biancheri, R. Carsetti, et al. 2007. Impairment of splenic IgM-memory but not switched-memory B cells in a patient with celiac disease and splenic atrophy. J Allergy Clin Immunol. 120: 1461-1463. (Pubitemid 350216592)
42. Puga, I., M. Cols, C. M. Barra, B. He, L. Cassis, M. Gentile, L. Comerma, et al. 2012. B cell-helper neutrophils stimulate the diversification and production of immunoglobulin in the marginal zone of the spleen. Nature. 13: 170-180.
43. Jacobi, A. M., H. Mei, B. F. Hoyer, I. M. Mumtaz, K. Thiele, A. Radbruch, G. R. Burmester, et al. 2010. HLA-DRhigh/CD27high plasmablasts indicate active disease in patients with systemic lupus erythematosus. Ann Rheum Dis. 69: 305-308.
44. Thiel, J., L. Kimmig, U. Salzer, M. Grudzien, D. Lebrecht, T. Hagena, R. Draeger, et al. 2011. Genetic CD21 deficiency is associated with hypogammaglobulinemia. J Allergy Clin Immunol. 129: 801-810.
45. Warnatz, K., A. Denz, R. Dräger, M. Braun, C. Groth, G. Wolff-Vorbeck, H. Eibel, et al. 2002. Severe deficiency of switched memory B cells (CD27(\+)IgM IgD in subgroups of patients with common variable immunodeficiency: a new approach to classify a heterogeneous disease. Blood 99: 1544-1551. (Pubitemid 34533024)
46. Moir, S., J. Ho, A. Malaspina, W. Wang, A. C. DiPoto, M. A. O'Shea, G. Roby, et al. 2008. Evidence for HIV-associated B cell exhaustion in a dysfunctional memory B cell compartment in HIV-infected viremic individuals. J Exper Med. 205: 1797-1805.
47. Visentini, M., M. Cagliuso, V. Conti, M. Carbonari, M. Cibati, G. Siciliano, C. Cristofoletti, et al. 2012. Clonal B cells of HCV-associated mixed cryoglobulinemia patients contain exhausted marginal zone-like and CD21 low cells overexpressing Stra13. Eur J Immunol. 42: 1468-1476.
48. Isnardi, I., Y.-S. Ng, L. Menard, G. Meyers, D. Saadoun, I. Srdanovic, J. Samuels, et al. 2010. Complement receptor 2/CD21-human naive B cells contain mostly autoreactive unresponsive clones. Blood 115: 5026-5036.